These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12895230)

  • 1. Bone marrow cell transfer of autoimmune diseases in a MRL strain of mice with a deficit in functional Fas ligand: dissociation of arteritis from glomerulonephritis.
    Ito MR; Ono M; Itoh J; Nose M
    Pathol Int; 2003 Aug; 53(8):518-24. PubMed ID: 12895230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular lesions in mice with a deficit in Fas-mediated apoptosis and their transfer.
    Nose M; Ito MR; Ono M; Terasaki S; Miyazawa M; Mori S
    Int J Cardiol; 1996 Aug; 54 Suppl():S11-20. PubMed ID: 9119511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand.
    Ito MR; Terasaki S; Itoh J; Katoh H; Yonehara S; Nose M
    Arthritis Rheum; 1997 Jun; 40(6):1054-63. PubMed ID: 9182916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.
    Nose M; Nishimura M; Kyogoku M
    Am J Pathol; 1989 Aug; 135(2):271-80. PubMed ID: 2782373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
    Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
    Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
    FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of macrophages in the development of arteritis in MRL strains of mice with a deficit in Fas-mediated apoptosis.
    Taniguchi Y; Ito MR; Mori S; Yonehara S; Nose M
    Clin Exp Immunol; 1996 Oct; 106(1):26-34. PubMed ID: 8870694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production.
    Nose M; Nishimura M; Ito MR; Toh J; Shibata T; Sugisaki T
    Am J Pathol; 1996 Nov; 149(5):1763-9. PubMed ID: 8909264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity in mice bearing lprcg: a novel mutant gene.
    Kimura M; Matsuzawa A
    Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci.
    Nose M; Nishihara M; Kamogawa J; Terada M; Nakatsuru S
    Rev Immunogenet; 2000; 2(1):154-64. PubMed ID: 11324688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
    Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
    J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
    Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
    J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transfers in X-irradiated mice congenic at the lpr locus: some paradoxical effects.
    Mosbach-Ozmen L; Loor F
    Thymus; 1987; 9(4):197-210. PubMed ID: 3313828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
    Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.
    Davidson WF; Giese T; Fredrickson TN
    J Exp Med; 1998 Jun; 187(11):1825-38. PubMed ID: 9607923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras.
    MacDonald GC; Kakkanaiah VN; Sobel ES; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):444-9. PubMed ID: 7527820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.
    Chu JL; Ramos P; Rosendorff A; Nikolić-Zugić J; Lacy E; Matsuzawa A; Elkon KB
    J Exp Med; 1995 Jan; 181(1):393-8. PubMed ID: 7528774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.